Drug Pricing Reforms Need A Rethink

BMI View: Egypt needs reforms to its regulatory framework to make it easier for drugs to be registered and reduce corruption. However, the proposed reform to the country?s medicine pricing regime will not win its appeal at the Supreme Administrative Court. Despite making medicine registration simpler, the proposed changes in Decree 373 will make generic drugs unaffordable for some Egyptian consumers, create legal loopholes and Infuriate multinational pharmaceutical companies.

To read the full article, please choose one of the following options: